Navigation Links
Kerrison style punch

ProductsKerrison style punch
Company Pilling Surgical
Item Kerrison style punch
Features 
Description Thru cut kerrison style punch 30 deg, 2.75 X 1.4 mm cut, 110 working length.
Info Pilling Surgical
Customer Service: (800) 334-9751

Related medicine products :

1. Bayonet Kerrison Rongeur
2. Love-Kerrison Rongeurs
3. Kerrison Rongeurs
4. Spurling Kerrison Rongeurs
5. Thin Footplate Kerrison Rongeurs
6. Foraminotomy Kerrison Rongeurs
7. Kerrison punches
8. Ferris-Smith Kerrison punches
9. Lov-Kerrison punches
10. Kerrison (Micro) Laminectomy Rongeur, with ejector
11. Kerrison (Micro) Laminectomie Rongeur, with ejector
Other Medicine News:Health News:Cardiff scientists study acute infection in end-stage kidney disease patients 2Health News:Statement by the National Patient Advocate Foundation on President-Elect Obama's Victory 2Health News:Pharmaceutical Industry Needs to Speed Up Transformation to Meet Changing Market Dynamics, According to Ernst & Young Report 2Health News:Pharmaceutical Industry Needs to Speed Up Transformation to Meet Changing Market Dynamics, According to Ernst & Young Report 3Health News:Pharmaceutical Industry Needs to Speed Up Transformation to Meet Changing Market Dynamics, According to Ernst & Young Report 4Health News:Conrad J. Heilman to Succeed Joseph S. Tempio as President and CEO of Tunnell Consulting 2Health News:Conrad J. Heilman to Succeed Joseph S. Tempio as President and CEO of Tunnell Consulting 3Health News:Corgenix Reports Financial Results for First Quarter of Fiscal 2009 2Health News:Corgenix Reports Financial Results for First Quarter of Fiscal 2009 3Health News:GLEH LA, a Nonprofit Affiliate of Gay & Lesbian Elder Housing, Announces New Program Director 2Health News:GLEH LA, a Nonprofit Affiliate of Gay & Lesbian Elder Housing, Announces New Program Director 3
Breaking Medicine Technology:NOVAVAX Announces Closing of Public Offering of 6,800,000 Shares of Common Stock 2Sangart, Inc. Initiates Phase IIa Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock 2Sangart, Inc. Initiates Phase IIa Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock 3Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 2Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 3Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 4Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 5Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 6Zimmer Holdings to Present at BMO Capital Markets Ninth Annual Focus on Healthcare Conference 53086 1Less Common Procedures Less Common Than Thought 53082 1Less Common Procedures Less Common Than Thought 53082 2Carboxytherapy and Mesotherapy Unproven Warns The Physicians Coalition for Injectable Safety 53079 1Carboxytherapy and Mesotherapy Unproven Warns The Physicians Coalition for Injectable Safety 53079 2Carboxytherapy and Mesotherapy Unproven Warns The Physicians Coalition for Injectable Safety 53079 3